Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide 1”

637 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 637 results

Not applicableStudy completedNCT05598008
What this trial is testing

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

Who this might be right for
Sexual Desire
University Hospital, Basel, Switzerland 85
Not applicableUnknownNCT03965000
What this trial is testing

Human Solute Carrier Family 5 Member 2 (SLC5A2) Deficiency and the Glucagon-Incretin Axis

Who this might be right for
Familial Renal GlucosuriaDiabetes MellitusCardiovascular Diseases
Medical University Innsbruck 10
Not applicableTemporarily pausedNCT01471509
What this trial is testing

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Who this might be right for
Type 2 DiabetesMetabolic Syndrome
Minneapolis Veterans Affairs Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Testing effectiveness (Phase 2)Study completedNCT05111912
What this trial is testing

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Who this might be right for
Obesity
Sciwind Biosciences APAC CO Pty. Ltd. 206
Post-approval studies (Phase 4)Study completedNCT00353834
What this trial is testing

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Joslin Diabetes Center 72
Not applicableStudy completedNCT03085511
What this trial is testing

High Quality Protein for Assisting With Weight Loss

Who this might be right for
Obesity
Texas Tech University 40
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Not applicableNot Yet RecruitingNCT06877208
What this trial is testing

The Effect of Glucagon on Cerebral Glucose Metabolism in Healthy Humans

Who this might be right for
Cerebral Glucose Metabolism
Nicolai Jacob Wewer Albrechtsen 12
Early research (Phase 1)Study completedNCT02692040
What this trial is testing

Study of the Gut Hormone Analogue G3215 in Adult Subjects

Who this might be right for
Diabetes MellitusObesity
Imperial College London 90
Large-scale testing (Phase 3)Study completedNCT00566189
What this trial is testing

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity
University of Campinas, Brazil 36
Large-scale testing (Phase 3)Study completedNCT05680155
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 211
Testing effectiveness (Phase 2)Study completedNCT01832532
What this trial is testing

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

Who this might be right for
Sleep ApneaSleep Disordered Breathing
Children's Hospital Medical Center, Cincinnati 34
Post-approval studies (Phase 4)UnknownNCT02055014
What this trial is testing

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

Who this might be right for
Type 2 DiabetesObesityDiabesity
Sandwell & West Birmingham Hospitals NHS Trust 72
Very early researchStudy completedNCT05093517
What this trial is testing

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4
Testing effectiveness (Phase 2)Looking for participantsNCT07497399
What this trial is testing

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 120
Early research (Phase 1)Study completedNCT04347252
What this trial is testing

Glucagon Regulation of Glucose Metabolism

Who this might be right for
Insulin Secretion
David D'Alessio, M.D. 19
Not applicableNot Yet RecruitingNCT07097987
What this trial is testing

Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion

Who this might be right for
Obesity
TCI Co., Ltd. 14
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Post-approval studies (Phase 4)Study completedNCT04053712
What this trial is testing

Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
Steno Diabetes Center Copenhagen 13
Load More Results